Evidence map›Paper›PMID 34185793›Full record

ArticlePloS one2021

Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.

George Mpekoulis, Efseveia Frakolaki, Styliani Taka, Anastasios Ioannidis, Alice G Vassiliou, Katerina I Kalliampakou, Kostas Patas, Ioannis Karakasiliotis, Vassilis Aidinis, Stylianos Chatzipanagiotou and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. ACE2: Friend or Foe in Post-COVID-19 Neurodegeneration?International journal of molecular sciences · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The crucial role of prolactin-lactogenic hormone in Covid-19.Molecular and cellular biochemistry · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. COVID-19: The cynosure of rise of Parkinson's disease.International review of neurobiology · 2022
    Article
  17. Article
  18. Treatment paradigms in Parkinson's Disease and Covid-19.International review of neurobiology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

George MpekoulisLaboratory of Molecular Virology, Hellenic Pasteur Institute, Athens, Greece.
Efseveia FrakolakiLaboratory of Molecular Virology, Hellenic Pasteur Institute, Athens, Greece.
Styliani TakaAllergy and Clinical Immunology Unit, 2nd Pediatric Clinic, National and Kapodistrian University of Athens, Athens, Greece.
Anastasios IoannidisDepartment of Nursing, University of Peloponnese, Sparti, Greece.
Alice G VassiliouFirst Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, National and Kapodistrian University of Athens Medical School, Evangelismos Hospital, Athens, Greece.ORCID 0000-0003-4984-0476
Katerina I KalliampakouLaboratory of Molecular Virology, Hellenic Pasteur Institute, Athens, Greece.
Kostas PatasDepartment of Medical Biopathology, Medical School, University of Athens, Eginition Hospital, Athens, Greece.
Ioannis KarakasiliotisLaboratory of Biology, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Vassilis AidinisInstitute for Bioinnovation, Biomedical Sciences Research Center "Alexander Fleming", Athens, Greece.
Stylianos ChatzipanagiotouDepartment of Medical Biopathology, Medical School, University of Athens, Eginition Hospital, Athens, Greece.
Emmanouil AngelakisDepartment of Diagnostics, Hellenic Pasteur Institute, Athens, Greece.
Dido VassilacopoulouSection of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Niki VassilakiLaboratory of Molecular Virology, Hellenic Pasteur Institute, Athens, Greece.ORCID 0000-0001-7992-3438
National and Kapodistrian University of Athens · GRPasteur Hellenic Institute · GRAlexander Fleming Biomedical Sciences Research Center · GRDemocritus University of Thrace · GRMéditerranée Infection Foundation · FRUniversity of Peloponnese · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

L-Dopa decarboxylase (DDC) is the most significantly co-expressed gene with ACE2, which encodes for the SARS-CoV-2 receptor angiotensin-converting enzyme 2 and the interferon-inducible truncated isoform dACE2. Our group previously showed the importance of DDC in viral infections. We hereby aimed to investigate DDC expression in COVID-19 patients and cultured SARS-CoV-2-infected cells, also in association with ACE2 and dACE2. We concurrently evaluated the expression of the viral infection- and interferon-stimulated gene ISG56 and the immune-modulatory, hypoxia-regulated gene EPO. Viral load and mRNA levels of DDC, ACE2, dACE2, ISG56 and EPO were quantified by RT-qPCR in nasopharyngeal swab samples from COVID-19 patients, showing no or mild symptoms, and from non-infected individuals. Samples from influenza-infected patients were analyzed in comparison. SARS-CoV-2-mediated effects in host gene expression were validated in cultured virus-permissive epithelial cells. We found substantially higher gene expression of DDC in COVID-19 patients (7.6-fold; p = 1.2e-13) but not in influenza-infected ones, compared to non-infected subjects. dACE2 was more elevated (2.9-fold; p = 1.02e-16) than ACE2 (1.7-fold; p = 0.0005) in SARS-CoV-2-infected individuals. ISG56 (2.5-fold; p = 3.01e-6) and EPO (2.6-fold; p = 2.1e-13) were also increased. Detected differences were not attributed to enrichment of specific cell populations in nasopharyngeal tissue. While SARS-CoV-2 virus load was positively associated with ACE2 expression (r≥0.8, p<0.001), it negatively correlated with DDC, dACE2 (r≤-0.7, p<0.001) and EPO (r≤-0.5, p<0.05). Moreover, a statistically significant correlation between DDC and dACE2 expression was observed in nasopharyngeal swab and whole blood samples of both COVID-19 and non-infected individuals (r≥0.7). In VeroE6 cells, SARS-CoV-2 negatively affected DDC, ACE2, dACE2 and EPO mRNA levels, and induced cell death, while ISG56 was enhanced at early hours post-infection. Thus, the regulation of DDC, dACE2 and EPO expression in the SARS-CoV-2-infected nasopharyngeal tissue is possibly related with an orchestrated antiviral response of the infected host as the virus suppresses these genes to favor its propagation.

Indexed as

Adaptor Proteins, Signal TransducingAdultAgedAngiotensin-Converting Enzyme 2Area Under CurveAromatic-L-Amino-Acid DecarboxylasesCOVID-19Dopa DecarboxylaseDown-RegulationEpithelial CellsErythropoietinFemaleHumansMaleMiddle AgedNasopharynxACE2 protein, humanAdaptor Proteins, Signal TransducingAngiotensin-Converting Enzyme 2Aromatic-L-Amino-Acid DecarboxylasesDDC protein, humanDopa DecarboxylaseEPO protein, humanErythropoietinIFIT1 protein, humanProtein IsoformsRNA-Binding Proteins

Identifiers

PMID34185793
PMCPMC8241096
OpenAlexW3173545700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.